| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 42, 1001-1020, Copyright © 1996 by American Association for Clinical Chemistry
W Schanzer
Institute of Biochemistry, German Sports University Cologne, Germany.
Anabolic androgenic steroids (AAS) are misused to a high extent in sports by athletes to improve their physical performance. Sports federations consider the use of these drugs in sports as doping. The misuse of AAS is controlled by detection of the parent AAS (when excreted into urine) and (or) their metabolites in urine of athletes. I present a review of the metabolism of AAS. Testosterone is the principal androgenic steroid and its metabolism is compared with that of AAS. The review is divided into two parts: the general metabolism of AAS, which is separated into phase I and phase II metabolism and includes a systematic discussion of metabolic changes in the steroid molecule according to the regions (A-D rings), and the specific metabolism of AAS, which presents the metabolism of 26 AAS in humans.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  S. T. Page, D. W. Lin, E. A. Mostaghel, D. L. Hess, L. D. True, J. K. Amory, P. S. Nelson, A. M. Matsumoto, and W. J. Bremner Persistent Intraprostatic Androgen Concentrations after Medical Castration in Healthy Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3850 - 3856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Schrader, M. Thevis, and W. Schanzer QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY Drug Metab. Dispos., August 1, 2006; 34(8): 1328 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Ayotte Significance of 19-norandrosterone in athletes' urine samples Br. J. Sports Med., July 1, 2006; 40(suppl_1): i25 - i29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kuuranne, M. Kurkela, M. Thevis, W. Schanzer, M. Finel, and R. Kostiainen GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., September 1, 2003; 31(9): 1117 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Z. Leder, D. H. Catlin, C. Longcope, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein Metabolism of Orally Administered Androstenedione in Young Men J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3654 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Le Bizec, M.-P. Montrade, F. Monteau, I. Gaudin, and F. Andre 4-Chlorotestosterone acetate metabolites in cattle after intramuscular and oral administrations Clin. Chem., May 1, 1998; 44(5): 973 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Catlin, C. K. Hatton, and S. H. Starcevic Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine Clin. Chem., July 1, 1997; 43(7): 1280 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Bowers Analytical advances in detection of performance-enhancing compounds Clin. Chem., July 1, 1997; 43(7): 1299 - 1304. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
